280 related articles for article (PubMed ID: 28470584)
41. Subcellular localization of peptidylarginine deiminase 2 and citrullinated proteins in brains of scrapie-infected mice: nuclear localization of PAD2 and membrane fraction-enriched citrullinated proteins.
Jang B; Shin HY; Choi JK; Nguyen du PT; Jeong BH; Ishigami A; Maruyama N; Carp RI; Kim YS; Choi EK
J Neuropathol Exp Neurol; 2011 Feb; 70(2):116-24. PubMed ID: 21343880
[TBL] [Abstract][Full Text] [Related]
42. PAD2 dysregulation and aberrant protein citrullination feature prominently in reactive astrogliosis and myelin protein aggregation in sporadic ALS.
Yusuf IO; Parsi S; Ostrow LW; Brown RH; Thompson PR; Xu Z
Neurobiol Dis; 2024 Mar; 192():106414. PubMed ID: 38253209
[TBL] [Abstract][Full Text] [Related]
43. Demyelination in vitro. Absorption studies demonstrate that galactocerebroside is a major target.
Raine CS; Johnson AB; Marcus DM; Suzuki A; Bornstein MB
J Neurol Sci; 1981 Oct; 52(1):117-31. PubMed ID: 6170737
[TBL] [Abstract][Full Text] [Related]
44. Dysmyelination and reduced myelin basic protein gene expression by oligodendrocytes of SHP-1-deficient mice.
Massa PT; Wu C; Fecenko-Tacka K
J Neurosci Res; 2004 Jul; 77(1):15-25. PubMed ID: 15197735
[TBL] [Abstract][Full Text] [Related]
45. Species-specificity of a panel of prion protein antibodies for the immunohistochemical study of animal and human prion diseases.
Furuoka H; Yabuzoe A; Horiuchi M; Tagawa Y; Yokoyama T; Yamakawa Y; Shinagawa M; Sata T
J Comp Pathol; 2007 Jan; 136(1):9-17. PubMed ID: 17270205
[TBL] [Abstract][Full Text] [Related]
46. Central nervous system myelin: structure, function, and pathology.
Deber CM; Reynolds SJ
Clin Biochem; 1991 Apr; 24(2):113-34. PubMed ID: 1710177
[TBL] [Abstract][Full Text] [Related]
47. The relationship between viral RNA, myelin-specific mRNAs, and demyelination in central nervous system disease during Theiler's virus infection.
Yamada M; Zurbriggen A; Fujinami RS
Am J Pathol; 1990 Dec; 137(6):1467-79. PubMed ID: 2260633
[TBL] [Abstract][Full Text] [Related]
48. Myelin phagocytosis and remyelination of macrophage-enriched central nervous system aggregate cultures.
Copelman CA; Diemel LT; Gveric D; Gregson NA; Cuzner ML
J Neurosci Res; 2001 Dec; 66(6):1173-8. PubMed ID: 11746450
[TBL] [Abstract][Full Text] [Related]
49. Myelin injury induces axonal transport impairment but not AD-like pathology in the hippocampus of cuprizone-fed mice.
Sun J; Zhou H; Bai F; Ren Q; Zhang Z
Oncotarget; 2016 May; 7(21):30003-17. PubMed ID: 27129150
[TBL] [Abstract][Full Text] [Related]
50. Myelin injury and degraded myelin vesicles in Alzheimer's disease.
Zhan X; Jickling GC; Ander BP; Liu D; Stamova B; Cox C; Jin LW; DeCarli C; Sharp FR
Curr Alzheimer Res; 2014 Mar; 11(3):232-8. PubMed ID: 24484278
[TBL] [Abstract][Full Text] [Related]
51. White matter involvement in sporadic Creutzfeldt-Jakob disease.
Caverzasi E; Mandelli ML; DeArmond SJ; Hess CP; Vitali P; Papinutto N; Oehler A; Miller BL; Lobach IV; Bastianello S; Geschwind MD; Henry RG
Brain; 2014 Dec; 137(Pt 12):3339-54. PubMed ID: 25367029
[TBL] [Abstract][Full Text] [Related]
52. Cortical network dysfunction caused by a subtle defect of myelination.
Poggi G; Boretius S; Möbius W; Moschny N; Baudewig J; Ruhwedel T; Hassouna I; Wieser GL; Werner HB; Goebbels S; Nave KA; Ehrenreich H
Glia; 2016 Nov; 64(11):2025-40. PubMed ID: 27470661
[TBL] [Abstract][Full Text] [Related]
53. The contributions of myelin and axonal caliber to transverse relaxation time in shiverer and neurofilament-deficient mouse models.
Dyakin VV; Chen Y; Branch CA; Veeranna ; Yuan A; Rao M; Kumar A; Peterhoff CM; Nixon RA
Neuroimage; 2010 Jul; 51(3):1098-105. PubMed ID: 20226865
[TBL] [Abstract][Full Text] [Related]
54. Activated cyclic AMP-response element binding protein (CREB) is expressed in a myelin-associated protein in chick.
Kim DW; Chang JH; Park SW; Jeon GS; Seo JH; Cho SS
Neurochem Res; 2005 Sep; 30(9):1133-7. PubMed ID: 16292506
[TBL] [Abstract][Full Text] [Related]
55. Loss of Myelin Basic Protein Function Triggers Myelin Breakdown in Models of Demyelinating Diseases.
Weil MT; Möbius W; Winkler A; Ruhwedel T; Wrzos C; Romanelli E; Bennett JL; Enz L; Goebels N; Nave KA; Kerschensteiner M; Schaeren-Wiemers N; Stadelmann C; Simons M
Cell Rep; 2016 Jul; 16(2):314-322. PubMed ID: 27346352
[TBL] [Abstract][Full Text] [Related]
56. A role for CXCL12 (SDF-1alpha) in the pathogenesis of multiple sclerosis: regulation of CXCL12 expression in astrocytes by soluble myelin basic protein.
Calderon TM; Eugenin EA; Lopez L; Kumar SS; Hesselgesser J; Raine CS; Berman JW
J Neuroimmunol; 2006 Aug; 177(1-2):27-39. PubMed ID: 16782208
[TBL] [Abstract][Full Text] [Related]
57. Lipid-bound, native-like, myelin basic protein. Batch-wise preparation and perspectives for use in demyelinating diseases.
Riccio P; Liuzzi GM; Quagliariello E
Mol Chem Neuropathol; 1990 Dec; 13(3):185-94. PubMed ID: 1712204
[TBL] [Abstract][Full Text] [Related]
58. Correlations of quantitative MRI metrics with myelin basic protein (MBP) staining in a murine model of demyelination.
Soustelle L; Antal MC; Lamy J; Rousseau F; Armspach JP; Loureiro de Sousa P
NMR Biomed; 2019 Sep; 32(9):e4116. PubMed ID: 31225675
[TBL] [Abstract][Full Text] [Related]
59. Abnormal myelinogenesis both in the white and gray matter of the attractin-deficient mv rat.
Izawa T; Yamate J; Franklin RJ; Kuwamura M
Brain Res; 2010 Feb; 1312():145-55. PubMed ID: 19931230
[TBL] [Abstract][Full Text] [Related]
60. Expression of myelin basic protein (MBP) epitopes in human non-neural cells revealed by two anti-MBP IgM monoclonal antibodies.
Chignola R; Cestari T; Guerriero C; Riviera AP; Ferrari S; Brendolan A; Gobbo M; Amato S; Sartoris S; Fracasso G; Liuzzi MG; Riccio P; Tridente G; Andrighetto G
Clin Exp Immunol; 2000 Dec; 122(3):429-36. PubMed ID: 11122251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
